Medical News

RSS

Drugmakers tout COVID-19 vaccines to refurbish their public image

Johnson & Johnson researchers working on a vaccine against the coronavirus are "just like the heroes in the hospitals" fighting to save patients, J&J CEO Alex Gorsky said on the "Today" show a few weeks ago.

18 May 2020

COVID-19 may lead to thrombosis in the lungs and subsequently multi organ failure

COVID-19, the disease caused by SARS-CoV-2, not only may lead to severe pneumonia but also to thrombosis in the lungs and, subsequently, to multi organ failure involving kidneys, liver and pancreas.

18 May 2020

People infected with hepatitis D are more prone to hepatocellular carcinoma

Of all the hepatitis viruses, D is the most poorly known.This small virus, which can only infect people already infected with Hepatitis B, has so far been little studied.

18 May 2020

ISE continues to support research community in the global effort to fight COVID-19

The current COVID-19 pandemic is having a huge impact on people across the globe and in these unprecedented times we consider it more important than ever that we continue to support the publication of relevant and timely research.

18 May 2020

Medicaid providers at the end of the line for federal COVID funding

Casa de Salud, a nonprofit clinic in Albuquerque, New Mexico, provides primary medical care, opioid addiction services and non-Western therapies, including acupuncture and reiki, to a largely low-income population.

18 May 2020

Neuroscientists discover anti-aging molecule that repairs age-related DNA damage

MIT neuroscientists have discovered that an enzyme called HDAC1 is critical for repairing age-related DNA damage to genes involved in memory and other cognitive functions.

18 May 2020

Climate change threatens prospects for progress in cancer prevention and control

Climate change threatens prospects for further progress in cancer prevention and control, increasing exposure to cancer risk factors and impacting access to cancer care, according to a new commentary by scientists from the American Cancer Society and Harvard T. H. Chan School of Public Health.

18 May 2020

New biodegradable antiviral filters developed for protective masks

The CSIC's associated unit in Polymer Technology in Castellón will study the biodegradation levels of the materials developed.

18 May 2020

Researchers are developing advanced measures to fight against COVID-types contagions

A research team from the University of Valencia, led by the professor of the Department of Computer Science Pedro Morillo, is developing a project to improve protection against infections in areas of high availability of health centres.

18 May 2020

Researchers develop potential drug compound for treating cancer

Researchers at the University of Eastern Finland have developed a new and promising drug compound for the treatment of cancer that inhibits natural amino acids from entering cancer cells.

18 May 2020

Avacta's SARS-COV-2 neutralizing Affimer reagents show therapeutic potential for COVID-19

Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that several of the Affimer reagents recently generated for development of a point-of-care COVID-19 antigen saliva test have now also been shown to block the interaction between the virus’ spike protein and ACE2, a receptor on human cells that is key to the virus infection pathway.

From Avacta Life Sciences Ltd. 18 May 2020

COVID-19 clinical trials show positive early results, says GlobalData

With the number of COVID-19 cases and deaths increasing with each passing day, the need for a therapeutic or a vaccine for the pandemic intensifies.

18 May 2020

Boehringer Ingelheim acquires Northern Biologics to expand cancer immunology portfolio

Boehringer Ingelheim today announced the acquisition of Northern Biologics Inc., a wholly owned subsidiary of Northern LP. By acquiring this entity, which focuses on therapeutic antibodies targeting the tumor microenvironment, Boehringer Ingelheim is now positioned at the forefront of the stromal biology space - an emerging area in cancer immunology.

From Boehringer Ingelheim International GmbH 18 May 2020

Research explores how human enzymes could be used to exacerbate COVID-19

Centenary Institute researchers have examined the critical role of human enzymes and the coronavirus in a newly published scientific review article that explores potential strategies for COVID-19 disease treatment and management.

18 May 2020

Interactive "Netflix" type platform for educators affected by COVID-19

The World Literacy Foundation announced today the development of an interactive "Netflix" type platform to equip educators with resources that have been affected by the indefinite school lockdown as a result of COVID-19.

18 May 2020

Most parents are concerned about the impact of health apps on young children

Health apps have become a popular tool among teens and adults to track fitness, weight loss, sleep and even menstrual cycles - but are they appropriate for tweens?

18 May 2020

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

Takeda Pharmaceutical Company Limited today announced that the company will present data from its expanding oncology pipeline and established product portfolio at two upcoming virtual scientific congresses: the 56th Annual Meeting of the American Society of Clinical Oncology, May 29-31 and the 25th Virtual Congress of the European Hematology Association, June 11-14.

18 May 2020

A novel approach to predict heart damage in COVID-19 patients

Johns Hopkins researchers recently received a $195,000 Rapid Response Research grant from the National Science Foundation to, using machine learning, identify which COVID-19 patients are at risk of adverse cardiac events such as heart failure, sustained abnormal heartbeats, heart attacks, cardiogenic shock and death.

18 May 2020

Oxford University vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

As the world continues to grapple with the coronavirus pandemic, many scientists, institutions, and pharmaceutical companies are working hard to develop an effective vaccine.

18 May 2020

Tobacco companies exploit UK’s menthol cigarette ban

Menthol cigarettes will be removed from shelves in the UK this Wednesday (20 May 2020), yet new research has found that tobacco companies failed to use the four-year phasing-in period (from 2016) to prepare for this week's ban.

18 May 2020

Medical News

Drugmakers tout COVID-19 vaccines to refurbish their public image

COVID-19 may lead to thrombosis in the lungs and subsequently multi organ failure

People infected with hepatitis D are more prone to hepatocellular carcinoma

ISE continues to support research community in the global effort to fight COVID-19

Medicaid providers at the end of the line for federal COVID funding

Neuroscientists discover anti-aging molecule that repairs age-related DNA damage

Climate change threatens prospects for progress in cancer prevention and control

New biodegradable antiviral filters developed for protective masks

Researchers are developing advanced measures to fight against COVID-types contagions

Researchers develop potential drug compound for treating cancer

Avacta's SARS-COV-2 neutralizing Affimer reagents show therapeutic potential for COVID-19

COVID-19 clinical trials show positive early results, says GlobalData

Boehringer Ingelheim acquires Northern Biologics to expand cancer immunology portfolio

Research explores how human enzymes could be used to exacerbate COVID-19

Interactive "Netflix" type platform for educators affected by COVID-19

Most parents are concerned about the impact of health apps on young children

Takeda to present oncology pipeline data at upcoming virtual scientific congresses

A novel approach to predict heart damage in COVID-19 patients

Oxford University vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

Tobacco companies exploit UK’s menthol cigarette ban

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News